Trial intelligence / Profile preview

Dapivirine Vaginal Ring in Lactating Women

NCT02808949Phase 1Completed

Sponsor
International Partnership for Microbicides
Start
Feb 2015
Primary completion
Mar 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of dapivirine in human immunodeficiency virus infection (HIV), sponsored by International Partnership for Microbicides. Primary endpoint: Pharmacokinetics at 14 days. Started Feb 2015; status: completed.

02

Drugs

dapivirine
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT02808949.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02808949.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call